Linoleic acid–rich oil versus blended oil for adults with insulin resistance
Official title: Role of Linoleic Acid in Cardiometabolic Health Beyond Its Lipid-lowering Effects, and Its Dietary and Pathophysiological Implications
Run by Pontificia Universidad Catolica de Chile · NCT07287514 · Data updated 2026-11-12
This trial will test whether taking a linoleic acid–rich oil daily for 8 weeks improves insulin resistance in adults who already have insulin resistance.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 20 Years to 60 Years |
| Sex | All |
| Enrollment | 120 (estimated) |
| Sponsor | Pontificia Universidad Catolica de Chile Academic / other |
| Locations | 1 site (Santiago, Santiago Metropolitan) |
| Status | Recruiting |
| Started | May 13, 2025 |
| Main results expected | October 2026 |
| Study ends | December 2026 |
| Registry record updated | December 17, 2025 |
| Trial ID | NCT07287514 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 20–60 with documented insulin resistance (HOMA-IR > 2.6) and at least one cardiometabolic risk factor who are not diabetic and are not taking medications that affect lipids or insulin sensitivity are ideal candidates.
✕Probably not a fit
People with diagnosed diabetes, prior clinical cardiovascular disease, recent bariatric surgery, pregnancy or lactation, malabsorption disorders, or regular use of excluded medications or PUFA supplements are unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
In a single-blind, randomized, parallel-group intervention, adults with insulin resistance will be assigned to take either a linoleic acid–rich oil supplement or a control blended oil each day for 8 weeks while keeping their usual diet and lifestyle. The main outcome is change in insulin resistance measured by HOMA-IR, with secondary outcomes including fasting glucose and insulin, lipid profile, inflammatory and oxidative stress markers, and body composition. Participants are adults aged 20–60 with HOMA-IR > 2.6 and at least one cardiometabolic risk factor, and people with diabetes, prior cardiovascular disease, or on certain medications are excluded. The trial is conducted at a single clinical research center and aims to provide controlled randomized data on the metabolic effects of increasing dietary linoleic acid.
Why it matters
Potential benefit: If successful, this intervention could offer a simple dietary supplement approach to improve insulin sensitivity and related metabolic markers in people with insulin resistance.
How similar studies have gone: Observational studies and meta-analyses have linked higher linoleic acid intake to better lipid profiles and lower diabetes risk, but well-controlled randomized trials testing metabolic outcomes remain limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Men and women aged 20 to 60 years. * Insulin resistance (HOMA-IR \> 2.6). * At least one cardiometabolic risk factor: abdominal obesity (waist circumference \> 90 cm in men or \> 80 cm in women); low HDL-cholesterol (\< 40 mg/dL in men or \< 50 mg/dL in women); elevated LDL-cholesterol (\> 70 / 100 / 130 mg/dL, according to estimated cardiovascular risk); or elevated blood pressure (≥ 130/85 mmHg). Exclusion Criteria: * Diabetes diagnosis. * Severe psychiatric illness. * Malabsorption disorders or previous bariatric surgery. * Pregnancy or lactation. * Previous clinical cardiovascular disease. * Regular use of medications that could influence study outcomes, including: lipid-lowering agents insulin sensitizers antihypertensive drugs anticoagulants antiretroviral therapy thyroid hormones oral corticosteroids immunosuppressants polyunsaturated fatty acid (PUFA) supplements. * Fasting serum triglycerides ≥ 500 mg/dL or LDL-cholesterol ≥ 190 mg/dL. * Body mass index (BMI) ≥ 35 kg/m². * Very high blood pressure. * Any additional condition that may limit adherence to the study.
Where it's running
-
Centro de Investigaciones Clínicas UC (CICUC) - Pontificia Universidad Católica de Chile
Santiago, Santiago Metropolitan, Chile Recruiting
Study contacts
- Principal investigator: Loni Berkowitz, PhD — Pontificia Universidad Catolica de Chile
- Study coordinator: Loni Berkowitz, PhD
- Email: lberkowi@uc.cl
- Phone: 23543862
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Endoscopic sleeve gastroplasty for people with obesity and MASH
This study will test whether endoscopic sleeve gastroplasty plus lifestyle changes helps adults with obesity and MASH lose weight and improve liver health compared with lifestyle changes alone.
-
Understanding how metabolism and inflammation affect diabetes in teens
This study is trying to see how body weight, lifestyle, and diet affect inflammation and metabolism in teens to better understand diabetes risk.
-
Effects of weight loss with and without exercise on metabolic health
This study is testing whether losing weight with exercise helps improve metabolic health more than just losing weight through dieting alone for people with obesity.
-
Cognitive-behavioral therapy and exercise training for teenage girls at risk for type 2 diabetes
This study is testing if cognitive-behavioral therapy, exercise training, or both can help teenage girls at risk for type 2 diabetes improve their health and reduce stress and depression.
-
Effects of exercise on fat tissue in obese individuals
This study tests how exercise affects fat tissue in people with obesity to see if it can help improve their metabolism and manage weight better.
-
Effects of Bariatric Surgery and Lifestyle Changes on Fat and Liver Health
This study is testing how bariatric surgery and lifestyle changes affect fat and liver health in people with obesity and related metabolic issues.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.